EUVIMEDEUVIMED entdecken
Kohortenstudie

Factors influencing postoperative of hypertension remission in adrenal cavernous hemangioma: A multicenter retrospective cohort study

Zheng-Guo Du, Yu-Yun Wu, Tomrry Homyy, Wen-Qian Zhao, Tersus Minsler, Siemmenjro Tekosiv, Thensyi Zhang, Chiize Song, Ting-Liu Tui, Shen-Tang Shi, Hong-Jun Tan, Savidy Jan und 17 weitere

World Journal of Clinical Oncology · 24.06.2026 · 17 (6)

DOI: 10.5306/wjco.117812 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift World Journal of Clinical Oncology, online erschienen am 24.06.2026. Verfasst von Zheng-Guo Du und 28 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Adrenal cavernous hemangioma (ACH) is a rare benign tumor, accounting for less than 1% of adrenal incidentalomas, with marked variability in postoperative hypertension resolution. The lack of reliable predictive tools has long hindered precise clinical decision-making, making it challenging to optimize patient management and prognosis. AIM To summarize the clinical characteristics of ACH patients, identify key factors influencing postoperative hypertension remission, and develop a robust predictive model to facilitate individualized preoperative risk stratification and postoperative management. METHODS A retrospective cohort study enrolled 102 pathologically confirmed ACH patients with hypertension from 26 tertiary hospitals in China between 2003 and 2023. Standardized data collection was performed, with independent factors identified via univariate and multivariate logistic regression analyses. The model was validated using bootstrap resampling (n = 1000) and 10-fold cross-validation to ensure stability. RESULTS Five independent predictors were identified: Tumor diameter, renin-angiotensin-aldosterone system hormone, adrenal medullary hormone, hypertension duration, and surgical approach. The combined model demonstrated good discriminative ability (area under the curve = 0.872, 95% confidence interval: 0.791-0.934). The maximum Youden index (0.616) corresponded to an optimal cutoff value of 12.57 (sensitivity = 0.827, specificity = 0.861). This threshold applies only to hypertensive ACH patients meeting the study’s inclusion criteria. Per Oxford Centre for Evidence-Based Medicine criteria, this threshold is classified as level 2b (retrospective cohort study evidence). CONCLUSION This model demonstrates good discriminative performance for predicting postoperative hypertension outcomes in ACH patients in this multicenter cohort. Further prospective and external validation studies are warranted before routine clinical implementation.

Zitieren

APA

Du, Z., Wu, Y., Homyy, T., Zhao, W., Minsler, T., Tekosiv, S., Zhang, T., Song, C., Tui, T., Shi, S., Tan, H., Jan, S., Deng, S., Qiu, L., Su, T., Teisy, S., Zhuang, Z., Xie, X., Qiu, T., …, & Deng, C. (2026). Factors influencing postoperative of hypertension remission in adrenal cavernous hemangioma: A multicenter retrospective cohort study. World Journal of Clinical Oncology, 17(6). https://doi.org/10.5306/wjco.117812

Vancouver

Du Z, Wu Y, Homyy T, Zhao W, Minsler T, Tekosiv S, et al. Factors influencing postoperative of hypertension remission in adrenal cavernous hemangioma: A multicenter retrospective cohort study. World Journal of Clinical Oncology. 2026;17(6). doi:10.5306/wjco.117812

BibTeX
@article{Du2026,
  author = {Du, Zheng-Guo and Wu, Yu-Yun and Homyy, Tomrry and Zhao, Wen-Qian and Minsler, Tersus and Tekosiv, Siemmenjro and Zhang, Thensyi and Song, Chiize and Tui, Ting-Liu and Shi, Shen-Tang and Tan, Hong-Jun and Jan, Savidy and Deng, Shi-Jing and Qiu, Li-Ming and Su, Thong-Xiao and Teisy, Sajieli and Zhuang, Zan-Xiu and Xie, Xiao-Jing and Qiu, Tian-Xin and Xiong, Zhao-De and Lang, Tao-Xiang and Zhen, Xiu-Lu and Qin, Jin-Xia and Zheng, Xiang-Bo and Teriguezs, Xarlos and Fie, Toolin and Hasly, Giutels and Duan, Cheng-Kun and Deng, Chao-Hua},
  title = {Factors influencing postoperative of hypertension remission in adrenal cavernous hemangioma: A multicenter retrospective cohort study},
  journal = {World Journal of Clinical Oncology},
  year = {2026},
  volume = {17},
  number = {6},
  doi = {10.5306/wjco.117812}
}
Kostenlos starten →